SAM
IBB icon

Silphium Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Silphium Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,500
Closed -$410K – 27
2014
Q3 		$410K Buy
+4,500
New +$395K 0.4% 46

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Silphium Asset Management's IBB Position: Q4 2014 in Review

Silphium Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2014, closing a stake of 4,500 shares — an estimated $410K sold.

Silphium Asset Management first reported a position in IBB in Q3 2014 and held it in 1 quarter. The position peaked at $410K in Q3 2014. 370 funds tracked by Wall St. Rank hold IBB as of Q4 2014.

  • Silphium Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2014 after selling out during the quarter.
  • Silphium Asset Management sold 4,500 iShares Biotechnology ETF shares in Q4 2014, an estimated $410K.
  • Silphium Asset Management first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 1 quarter.
  • Silphium Asset Management's iShares Biotechnology ETF position peaked at $410K in Q3 2014.
  • 370 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2014.

Based on Silphium Asset Management's 13F filing for Q4 2014, filed 30 Jan 2025.